Press Releases

Press Releases

News, Events, Updates, Breakthroughs

Journalists may direct questions to Or click here for direct contact information for Daiichi Sankyo U.S. Public Affairs team

Press announcements are archived by release date, searchable by topic:

From To
Date Title
Mon Dec 11 00:00:00 GMT-04:00 2017
Daiichi Sankyo Presents Phase 1 Data for EZH1/2 Dual Inhibitor DS-3201 in Patients with Non-Hodgkin ...
PDF (252 KB)
Thu Dec 07 00:00:00 GMT-04:00 2017
Daiichi Sankyo Presents Updated Data for DS-8201 in Patients with HER2-Expressing Breast Cancer at ...
PDF (190 KB)
Fri Dec 01 00:00:00 GMT-04:00 2017
Daiichi Sankyo and Translational Sciences Conclude Agreement, after Successful Phase 1a Trial, as ...
PDF (194 KB)
Showing 41 - 43 of 43 results.

Press Release More Stories

More Stories

Who We Are

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability..

read more ...